Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, CryoPort Inc’s stock clocked out at $6.24, down -12.11% from its previous closing price of $7.10. In other words, the price has decreased by -$12.11 from its previous closing price. On the day, 0.6 million shares were traded. CYRX stock price reached its highest trading level at $7.12 during the session, while it also had its lowest trading level at $6.21.
Ratios:
To gain a deeper understanding of CYRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.94 and its Current Ratio is at 5.29. In the meantime, Its Debt-to-Equity ratio is 0.62 whereas as Long-Term Debt/Eq ratio is at 0.57.
On December 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $11.
Jefferies Downgraded its Buy to Hold on August 07, 2024, whereas the target price for the stock was revised from $20 to $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 17 ’25 when ZECCHINI EDWARD J sold 1,140 shares for $6.29 per share. The transaction valued at 7,173 led to the insider holds 66,911 shares of the business.
STEFANOVICH ROBERT sold 1,659 shares of CYRX for $10,438 on Mar 17 ’25. The Chief Financial Officer now owns 191,419 shares after completing the transaction at $6.29 per share. On Mar 17 ’25, another insider, Sawicki Mark W, who serves as the Chief Scientific Officer of the company, sold 2,092 shares for $6.29 each. As a result, the insider received 13,162 and left with 85,436 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 354363968 and an Enterprise Value of 334669824. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.36 while its Price-to-Book (P/B) ratio in mrq is 0.85. Its current Enterprise Value per Revenue stands at 1.465 whereas that against EBITDA is -9.464.
Stock Price History:
The Beta on a monthly basis for CYRX is 1.81, which has changed by -0.65562916 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, CYRX has reached a high of $20.10, while it has fallen to a 52-week low of $4.58. The 50-Day Moving Average of the stock is -8.07%, while the 200-Day Moving Average is calculated to be -18.98%.
Shares Statistics:
It appears that CYRX traded 389.08K shares on average per day over the past three months and 606720 shares per day over the past ten days. A total of 49.91M shares are outstanding, with a floating share count of 48.07M. Insiders hold about 3.69% of the company’s shares, while institutions hold 95.73% stake in the company. Shares short for CYRX as of 1740700800 were 2046167 with a Short Ratio of 5.26, compared to 1738281600 on 2007584. Therefore, it implies a Short% of Shares Outstanding of 2046167 and a Short% of Float of 4.9200002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
